Literature DB >> 20305757

Fatty liver disease in children: eat now pay later.

Ruth M L De Bruyne1, Emer Fitzpatrick, Anil Dhawan.   

Abstract

INTRODUCTION: With the recent epidemic in childhood obesity, nonalcoholic fatty liver disease (NAFLD) has become an emerging problem and a common cause of chronic liver disease in children.
METHODS: In this review, the most recent insights on the pathogenesis, diagnosis, natural history, and treatment of NAFLD in children are discussed.

Entities:  

Keywords:  Children; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Obesity

Year:  2010        PMID： 20305757      PMCID： PMC2836438          DOI： 10.1007/s12072-009-9160-z

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


  90 in total

Review 1.  Diagnostic accuracy of the BMI for age in paediatrics.

Authors:  J J Reilly
Journal:  Int J Obes (Lond)       Date:  2006-04       Impact factor: 5.095

2.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

3.  Non-alcoholic steatohepatitis over multiple generations.

Authors:  Christine Carter-Kent; Ariel E Feldstein
Journal:  Dig Dis Sci       Date:  2009-07-23       Impact factor: 3.199

4.  Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.

Authors:  Jeffrey B Schwimmer; Nancy McGreal; Reena Deutsch; Milton J Finegold; Joel E Lavine
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

5.  Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.

Authors:  I R Willner; B Waters; S R Patil; A Reuben; J Morelli; C A Riely
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

6.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Authors:  Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

7.  Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.

Authors:  Leon A Adams; Max Bulsara; Enrico Rossi; Bastiaan DeBoer; David Speers; Jacob George; James Kench; Geoffrey Farrell; Geoffrey W McCaughan; Gary P Jeffrey
Journal:  Clin Chem       Date:  2005-07-28       Impact factor: 8.327

8.  Vitamin E treatment in pediatric obesity-related liver disease: a randomized study.

Authors:  Pietro Vajro; Claudia Mandato; Adriana Franzese; Edmondo Ciccimarra; Stefania Lucariello; Marcella Savoia; Grazia Capuano; Fiorella Migliaro
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-01       Impact factor: 2.839

9.  Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

Authors:  S A Harrison; D Oliver; H L Arnold; S Gogia; B A Neuschwander-Tetri
Journal:  Gut       Date:  2008-04-04       Impact factor: 23.059

10.  Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

Authors:  Valerio Nobili; Julie Parkes; Gianfranco Bottazzo; Matilde Marcellini; Richard Cross; Daniel Newman; Francesco Vizzutti; Massimo Pinzani; William M Rosenberg
Journal:  Gastroenterology       Date:  2008-09-20       Impact factor: 22.682
View more
  12 in total

1.  Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1 c pathway.

Authors:  Ju-Hee Lee; Ji Yun Jung; Eun Jeong Jang; Kyung Hwan Jegal; Soo Young Moon; Sae Kwang Ku; Seung Ho Kang; Il Je Cho; Sook Jahr Park; Jong Rok Lee; Rong Jie Zhao; Sang Chan Kim; Young Woo Kim
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-14

2.  Keratin 18, Apoptosis, and Liver Disease in Children.

Authors:  Yanci O Mannery; Craig J McClain; Miriam B Vos
Journal:  Curr Pediatr Rev       Date:  2011-11

Review 3.  Hepatic steatosis and Type 2 diabetes: current and future treatment considerations.

Authors:  John Richard; Ildiko Lingvay
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-03

4.  Post-mortem MRI reveals CPT2 deficiency after sudden infant death.

Authors:  Karim Bouchireb; Anne-Marie Teychene; Odile Rigal; Pascale de Lonlay; Vassili Valayannopoulos; Joel Gaudelus; Nicolas Sellier; J P Bonnefont; Michèle Brivet; Loic de Pontual
Journal:  Eur J Pediatr       Date:  2010-07-27       Impact factor: 3.183

5.  Genomic insights into early-onset obesity.

Authors:  Hélène Choquet; David Meyre
Journal:  Genome Med       Date:  2010-06-23       Impact factor: 11.117

Review 6.  Non-alcoholic Fatty liver disease in children.

Authors:  Cristina Singer; Polixenia Stancu; Simona Coşoveanu; Alina Botu
Journal:  Curr Health Sci J       Date:  2014-08-04

7.  Genome-wide expression in visceral adipose tissue from obese prepubertal children.

Authors:  Concepción M Aguilera; Carolina Gomez-Llorente; Inés Tofe; Mercedes Gil-Campos; Ramón Cañete; Ángel Gil
Journal:  Int J Mol Sci       Date:  2015-04-08       Impact factor: 5.923

Review 8.  Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.

Authors:  Maria Grazia Clemente; Claudia Mandato; Marco Poeta; Pietro Vajro
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

9.  Long-term metabolic effects of malnutrition: Liver steatosis and insulin resistance following early-life protein restriction.

Authors:  Prasad S Dalvi; Steven Yang; Nathan Swain; Junsoo Kim; Senjuti Saha; Celine Bourdon; Ling Zhang; Rose Chami; Robert H J Bandsma
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

10.  Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis.

Authors:  Veronica Marin; Silvia Gazzin; Sabrina E Gambaro; Matteo Dal Ben; Sonia Calligaris; Monica Anese; Alan Raseni; Claudio Avellini; Pablo J Giraudi; Claudio Tiribelli; Natalia Rosso
Journal:  Nutrients       Date:  2017-09-12       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.